NAUT

Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Get 50% Off Elite

Peers: SEER QSI QTRX LAB TWST ABSI CDXS PACB TXG TECH

| Held by: IWM VTI IWN VXF VTWO IWC BUSM IWO VTWV RSSL

Scroll to Statements

Index	RUT
Market Cap	316.52M
Enterprise Value	256.68M
Income	-58.58M
Sales	0.42M
Book/sh	0.92
Cash/sh	0.68
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	130
IPO	Aug 07, 2020

P/E	-
Forward P/E	-
PEG	-
P/S	753.61
P/B	2.71
P/C	3.66
P/FCF	-
EV/EBITDA	-
EV/Sales	611.13
Quick Ratio	9.25
Current Ratio	9.25
Debt/Eq	0.23
LT Debt/Eq	0.19
Option/Short	Yes / Yes

EPS (ttm)	-0.46
EPS next Y	-0.48
EPS next Q	-0.14
EPS this Y	-3.19%
EPS next Y	0.00%
EPS next 5Y	1.68%
EPS past 3/5Y	-0.17% 0.21%
Sales past 3/5Y	- -
EPS Y/Y TTM	7.31%
Sales Y/Y TTM	-
EPS Q/Q	-14.33%
Sales Q/Q	-
Earnings	Oct 27 BMO
EPS/Sales Surpr.	14.29% 13.43%

Insider Own	41.98%
Insider Trans	-8.55%
Inst Own	27.58%
Inst Trans	-4.85%
ROA	-33.49%
ROE	-41.01%
ROIC	-42.10%
Gross Margin	-1242.22%
Oper. Margin	-15105.66%
Profit Margin	-13816.75%
SMA20	-2.36%
SMA50	36.86%
SMA200	16.85%
Trades

Shs Outstand	127.33M
Shs Float	73.90M
Short Float	7.90%
Short Ratio	1.02
Short Interest	5.84M
52W High	4.31 -42.34%
52W Low	0.84 195.45%
Volatility	11.19% 18.08%
ATR (14)	0.36
RSI (14)	53.93
Beta	0.68
Rel Volume	0.66
Avg Volume	5.75M
Volume	2,431,981

Perf Week	8.52%
Perf Month	21.22%
Perf Quarter	179.21%
Perf Half Y	-15.76%
Perf YTD	27.44%
Perf Year	49.70%
Perf 3Y	-6.23%
Perf 5Y	-52.21%
Perf 10Y	-
Recom	1.00
Target Price	4.00
Prev Close	2.32
Price	2.48
Change %	7.11%

Consensus

Strong Buy

Avg. Price Target

$4.00

Implied Upside

+61.0%

Analysts7incl. previous ratings

Rating Distribution4 Buy · 2 Hold · 1 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
Sep 29, 2026	Initiated	RRoth Capital	Buy	$3.50	+40.8%
Sep 09, 2026	Initiated	LLeerink Partners	Outperform	$4	+61.0%
Dec 05, 2024	Downgrade	GGoldman	Neutral → Sell	$1.75	-29.6%
Jun 27, 2024	Initiated	GGuggenheim	Buy	$6	+141.4%
Jun 03, 2024	Resumed	JJefferies	Hold	$3	+20.7%
Jan 06, 2022	Initiated	MMorgan Stanley	Equal-Weight	$8	+221.9%
Nov 02, 2021	Initiated	CCowen	Outperform
Aug 04, 2021	Initiated	GGoldman	Neutral	$10	+302.4%
Jul 13, 2021	Initiated	JJefferies	Buy	$13	+423.1%

Oct-27-26 11:46AM	Nautilus Beats On A Narrower-Than-Expected Loss, But Rising Spending And A Looming Raise Shadow Strong Proteoform Data (Earnings Whispers) +18.44%
06:00AM	Nautilus to Measure Proteoforms Driving Alzheimer's Disease and Cancer in ARPA-H-Funded SEEDS Consortium (GlobeNewswire)
06:00AM	Nautilus Biotechnology Reports Third Quarter 2026 Financial Results (GlobeNewswire)
Oct-15-26 08:00AM	Nautilus Biotechnology to Announce Third Quarter 2026 Financial Results on October 27, 2026 (GlobeNewswire)
Sep-04-26 08:00AM	Nature Methods Publication Reveals Deep Insights into Functional Biology through First-of-its-Kind Quantification of Tau Proteoforms (GlobeNewswire)
05:01PM	Loading…
Jul-28-26 05:01PM	Nautilus Biotechnology Inc (NAUT) Q2 2026 Earnings Call Highlights: Strategic Shifts and ... (GuruFocus.com) -27.71% -13.33%
08:00AM	Nautilus Biotechnology Reports Second Quarter 2026 Financial Results (GlobeNewswire)
Jul-08-26 08:00AM	Nautilus Biotechnology to Announce Second Quarter 2026 Financial Results on July 28, 2026 (GlobeNewswire) +5.33%
Apr-29-26 03:05AM	Nautilus Biotechnology Inc (NAUT) Q1 2026 Earnings Call Highlights: Strategic Advances Amid ... (GuruFocus.com)
Apr-28-26 08:00AM	Nautilus Biotechnology Reports First Quarter 2026 Financial Results (GlobeNewswire)
Apr-09-26 08:00AM	Nautilus Biotechnology to Announce First Quarter 2026 Financial Results on April 28, 2026 (GlobeNewswire)
Mar-24-26 08:00AM	Nautilus Biotechnology to Participate in the Investor Summit Group Virtual Conference (GlobeNewswire) +9.12%
Mar-18-26 08:00AM	Nautilus Biotechnology Announces Baylor College of Medicine as First Early Access Program Customer for Voyager Platform (GlobeNewswire)
Mar-02-26 08:00AM	Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of Sales (GlobeNewswire)
Feb-26-26 05:48PM	Nautilus Biotechnology Q4 Earnings Call Highlights (MarketBeat) -16.26%
04:07PM	Loading…
04:07PM	Nautilus Biotechnology Inc (NAUT) Q4 2025 Earnings Call Highlights: Strategic Advances and ... (GuruFocus.com)
08:00AM	Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2025 Financial Results (GlobeNewswire)
Feb-24-26 08:00AM	Nautilus Biotechnology Unveils Voyager Platform, Enabling Single-Molecule Iterative Mapping, at US HUPO 2026 (GlobeNewswire) +5.19%
Feb-19-26 04:05PM	Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference (GlobeNewswire) +7.84%
Feb-05-26 08:00AM	Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 (GlobeNewswire)
Jan-28-26 08:00AM	Nautilus Biotechnology and Weill Cornell Medicine-Qatar Collaborate with The Michael J. Fox Foundation to Advance Single-Molecule Proteomics Research in Parkinson's Disease (GlobeNewswire) -7.62%
Jan-08-26 08:00AM	Nautilus Biotechnology Launches Early Access Program for Novel Single-Molecule Proteomics Platform, Starting with Tau Proteoforms Assay (GlobeNewswire)
Nov-03-25 08:00AM	Nautilus Biotechnology Reports Successful Installation and Testing of its First Field Evaluation Unit at the Buck Institute for Research on Aging (GlobeNewswire) +39.10%
Oct-28-25 08:00AM	Nautilus Biotechnology Reports Third Quarter 2025 Financial Results (GlobeNewswire) +5.93%
Oct-07-25 08:00AM	Nautilus Biotechnology to Announce Third Quarter 2025 Financial Results on October 28, 2025 (GlobeNewswire)
Aug-27-25 08:00AM	Nautilus Biotechnology to Participate in Upcoming September Investor Conferences (GlobeNewswire)
Jul-31-25 08:00AM	Nautilus Biotechnology Reports Second Quarter 2025 Financial Results (GlobeNewswire)
Jul-30-25 08:00AM	Nautilus Biotechnology Announces Agreement with the Allen Institute, Further Validating its Approach to Single-Molecule Proteomics (GlobeNewswire)
Jul-15-25 08:00AM	Nautilus Biotechnology to Announce Second Quarter 2025 Financial Results on July 31, 2025 (GlobeNewswire) -8.59%
May-27-25 08:00AM	Nautilus Biotechnology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference (GlobeNewswire) +5.59%
03:10AM	Loading…
Apr-30-25 03:10AM	Nautilus Biotechnology Inc (NAUT) Q1 2025 Earnings Call Highlights: Strategic Cost Reductions ... (GuruFocus.com) -6.21%
Apr-29-25 01:01PM	Nautilus Biotechnology, Inc. (NAUT) Q1 2025 Earnings Call Transcript (Seeking Alpha) +7.97%
08:00AM	Nautilus Biotechnology Reports First Quarter 2025 Financial Results (GlobeNewswire)
Apr-16-25 08:00AM	Nautilus Biotechnology to Announce First Quarter 2025 Financial Results on April 29, 2025 (GlobeNewswire) -6.08%
Feb-28-25 02:16AM	Nautilus Biotechnology Inc (NAUT) Q4 2024 Earnings Call Highlights: Progress in Proteome ... (GuruFocus.com) +11.11%
Feb-27-25 08:00AM	Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2024 Financial Results (GlobeNewswire) -18.18%
Feb-18-25 08:00AM	Nautilus Biotechnology to Participate in the TD Cowen 45th Annual Healthcare Conference (GlobeNewswire)
Feb-06-25 08:00AM	Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025 (GlobeNewswire)
Oct-31-24 08:00AM	Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research's Distinguished Investigator Award (GlobeNewswire)
Oct-30-24 08:00AM	Nautilus Biotechnology to Participate in the Inaugural Guggenheim Healthcare Conference (GlobeNewswire)
03:07AM	Nautilus Biotechnology Inc (NAUT) Q3 2024 Earnings Call Highlights: Strategic Advances and ... (GuruFocus.com)
Oct-29-24 08:00AM	Nautilus Biotechnology Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Oct-08-24 08:00AM	Nautilus Biotechnology to Announce Third Quarter 2024 Financial Results on October 29, 2024 (GlobeNewswire)
Sep-17-24 08:00AM	Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing Officer (GlobeNewswire)
Aug-14-24 08:00AM	Nautilus Biotechnology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference (GlobeNewswire)
Jul-30-24 08:00AM	Nautilus Biotechnology Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Jul-09-24 08:00AM	Nautilus Biotechnology to Announce Second Quarter 2024 Financial Results on July 30, 2024 (GlobeNewswire)
May-23-24 08:00AM	Nautilus Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference (GlobeNewswire)
May-03-24 12:00PM	Nautilus Biotechnology (NAUT) Upgraded to Buy: Here's What You Should Know (Zacks)
May-01-24 11:11AM	Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q1 2024 Earnings Call Transcript (Insider Monkey) +9.45%
03:08AM	Nautilus Biotechnology Inc (NAUT) Q1 2024 Earnings Call Transcript Highlights: A Detailed ... (GuruFocus.com)
Apr-30-24 11:54AM	NAUT Stock Earnings: Nautilus Biotechnology Beats EPS for Q1 2024 (InvestorPlace)
08:00AM	Nautilus Biotechnology Reports First Quarter 2024 Financial Results (GlobeNewswire)
07:36AM	Nautilus Biotechnology Inc (NAUT) Q1 2024 Earnings: Narrower Loss Than Expected (GuruFocus.com)
Apr-11-24 08:00AM	Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024 (GlobeNewswire)
Feb-28-24 08:00AM	Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2023 Financial Results (GlobeNewswire)
07:36AM	Nautilus Biotechnology Inc (NAUT) Reports Fiscal Year 2023 Financial Results (GuruFocus.com)
Feb-22-24 08:00AM	Nautilus Biotechnology to Participate in the TD Cowen 44 Annual Healthcare Conference (GlobeNewswire)
Feb-07-24 08:00AM	Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024 (GlobeNewswire)
Nov-30-23 08:00AM	Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with US HUPO Computational Proteomics Award (GlobeNewswire)
Nov-01-23 08:05AM	Nautilus Biotechnology Appoints Martin Huber, Ph.D., as Vice President of Biochemistry and Flow Cell Development (GlobeNewswire)
Oct-31-23 08:05AM	Nautilus Biotechnology Reports Third Quarter 2023 Financial Results (GlobeNewswire) +9.40%
Oct-11-23 08:05AM	Nautilus Biotechnology to Announce Third Quarter Financial Results on October 31, 2023 (GlobeNewswire)
Sep-06-23 07:30AM	Nautilus Biotechnology to Participate in Upcoming September Investor Conferences (GlobeNewswire)
Aug-04-23 08:00AM	Nautilus Biotechnology to Participate in Upcoming August Investor Conferences (GlobeNewswire)
Aug-02-23 07:30AM	Nautilus Biotechnology Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Jul-11-23 09:23AM	Nautilus Biotechnology to Announce Second Quarter Financial Results on August 2, 2023 (GlobeNewswire)
May-24-23 08:05AM	Nautilus Biotechnology to Participate in Upcoming June Investor Conferences (GlobeNewswire)
May-02-23 06:30AM	Nautilus Biotechnology Reports First Quarter 2023 Financial Results (GlobeNewswire) -10.63%
Apr-18-23 04:05PM	Nautilus Biotechnology to Announce First Quarter Financial Results on May 2, 2023 (GlobeNewswire) -6.43%
Mar-23-23 08:00AM	Nautilus Biotechnology to Participate in B. Riley Securities Disruptive Biotech Enabling Technologies Proteomics, Virtual Conference (GlobeNewswire)
Mar-07-23 08:00AM	Nautilus Biotechnology Announces First Access Challenge Winners (GlobeNewswire)
Feb-23-23 06:05AM	Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2022 Financial Results (GlobeNewswire) -7.00%
Feb-21-23 08:00AM	Nautilus Biotechnology to Participate in the 43rd Annual Cowen Health Care Conference (GlobeNewswire) -10.31%
Jan-26-23 08:00AM	Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023 (GlobeNewswire)
07:45AM	Nautilus Biotechnology Expands to San Diego (GlobeNewswire)
Jan-19-23 08:00AM	Nautilus Biotechnology Partners with the Translational Genomics Research Institute (TGen) to Investigate Applications of Single-Molecule Proteomic Analysis in Diffuse Intrinsic Pontine Glioma (DIPG) (GlobeNewswire)
Nov-16-22 08:00AM	Nautilus Biotechnology Launches First Access Challenge (GlobeNewswire) -6.47%
Nov-01-22 06:05AM	Nautilus Biotechnology Reports Third Quarter 2022 Financial Results (GlobeNewswire)
Oct-05-22 08:00AM	Nautilus Biotechnology to Announce Third Quarter 2022 Financial Results on November 1, 2022 (GlobeNewswire) -7.26%
Sep-23-22 08:00AM	Nautilus Biotechnology to Participate in the Capital One Spatial Biology & Proteomics Summit (GlobeNewswire)
Sep-01-22 08:00AM	Nautilus Biotechnology Joins Human Proteome Organization (HUPO) Industrial Advisory Board (GlobeNewswire)
Aug-30-22 08:00AM	Nautilus Biotechnology to Participate in the Morgan Stanley Global Healthcare Conference (GlobeNewswire)
Aug-11-22 06:30AM	Sujal Patel Is The Co-Founder of Nautilus Biotechnology, Inc. (NASDAQ:NAUT) And Just Spent US$146k On Shares (Simply Wall St.)
Aug-02-22 06:48AM	Nautilus Biotechnology Reports Second Quarter 2022 Financial Results (GlobeNewswire)
Aug-01-22 04:05PM	Nautilus Biotechnology Appoints Eric Spence as Vice President of Instrument Engineering and Ken Kuhn, Ph.D., as Vice President of Reagent and Platform Development (GlobeNewswire)
Jul-13-22 08:00AM	Nautilus Biotechnology to Announce Second Quarter 2022 Financial Results on August 2, 2022 (GlobeNewswire)
May-12-22 06:28AM	Trade Alert: The Co-Founder Of Nautilus Biotechnology, Inc. (NASDAQ:NAUT), Sujal Patel, Has Just Spent US$198k Buying A Few More Shares (Simply Wall St.) +6.81%
May-03-22 06:00AM	Nautilus Biotechnology Reports First Quarter 2022 Financial Results (GlobeNewswire)
Apr-12-22 08:00AM	Nautilus Biotechnology Appoints Gwen Weld as Chief People Officer and Sheri Wilcox, Ph.D., as Vice President of Affinity Reagent Development (GlobeNewswire)
Apr-07-22 08:00AM	Nautilus Biotechnology to Announce First Quarter 2022 Financial Results on May 3, 2022 (GlobeNewswire)
Apr-04-22 08:00AM	Nautilus Biotechnology to Present at EuPA and AACR Meetings (GlobeNewswire)
Mar-31-22 04:05PM	Nautilus Biotechnology Appoints Karen Akinsanya, Ph.D., to Board of Directors (GlobeNewswire)
Mar-05-22 07:22AM	What Percentage Of Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Shares Do Insiders Own? (Simply Wall St.)
Feb-24-22 06:00AM	Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2021 Financial Results (GlobeNewswire) +8.43%
Feb-16-22 04:05PM	Nautilus to Participate in the 42nd Annual Cowen Health Care Conference (GlobeNewswire)
Feb-02-22 01:38PM	Clarius Group, LLC Buys BTC BlackRock Ultra Short-Term Bond ETF, , Vanguard Ultra-Short Bond ... (GuruFocus.com)
Jan-27-22 08:00AM	Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2021 Financial Results on February 24, 2022 (GlobeNewswire) -6.75%
Dec-16-21 01:07PM	A look at insider stock sales among Portland-area companies in 2021 (Photos) (American City Business Journals)
Dec-05-21 06:39AM	Insider Buying: The Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Co-Founder Just Bought 1.5% More Shares (Simply Wall St.)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
AH Equity Partners Bio II, L.L	10% Owner	Jun 02 '26	Sale	2.35	5,000,000	11,750,000	971,885	Jun 04 04:53 PM
Patel Sujal M	CEO, President, and Secretary	Mar 04 '26	Buy	2.61	25,000	65,238	10,366,721	Mar 04 06:37 PM

Nautilus Biotechnology, Inc. is a development stage life sciences company, which creates platform technology for quantifying and unlocking the complexity of the proteome. Its products include Proteome Analysis System, Reagent Kits, and Software and Analysis. The company was founded by Sujal M. Patel and Parag Mallick in 2016 and is headquartered in Seattle, WA.

Co-FounderMr. Sujal M. Patel

Co-FounderDr. Parag Mallick Ph.D.

CFO & TreasurerMs. Anna Mowry

General CounselMr. Matthew B. Murphy ESQ.

Vice President of Global SalesMs. Amber Faust

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

All the Features.Half the Price.

Nautilus Biotechnology Inc

Upgrade your Finviz experience

All the Features.
Half the Price.